NPI registry status
Active
2026 NPPES data Physician Assistant NPI 1821312026 P.A.-C
Verify on CMS → Bindu Alakot, P.A.-C
Physician Assistant in Dallas, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 149,975 in Physician Assistant, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 411 beneficiaries · Physician Assistant avg: 790
Generic prescribing
85%
generic claims · 13% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
90.1/100
▲ 7 pts above national avg 83.1 · Exceptional
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Bindu Alakot, P.A.-C reported a CMS MIPS final score of 90.1/100 - above the 83.1 national average - and filed 1,108 Medicare Part D claims in 2023.
- 90.1/100
- MIPS score · +7 vs avg
- 1K
- Part D claims, 2023
- 85%
- generic prescribing
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Bindu Alakot, P.A.-C's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
90 Top 40% higher than 60% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Bindu Alakot, P.A.-C sits
This provider among physician assistant peers
Across the 27,054 physician assistant providers who report both Medicare Part D prescribing and a MIPS quality score, Bindu Alakot, P.A.-C writes more Part D claims than 84% of them and scores higher on MIPS quality than 59% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one physician assistant peer from a representative sample of 60; the gold marker is Bindu Alakot, P.A.-C. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Bindu Alakot, P.A.-C?
High performer (top quartile)Primary specialty
Physician Assistant
Medicare Part D claims
1,108 40% vs specialty avg
MIPS final score
90.1/100 7 pts vs avg
Specialty distribution in Texas
How Physician Assistant compares to other specialties among Texas providers
Medicare quality performance, MIPS
Bindu Alakot, P.A.-C's 2023 MIPS final score plotted against the Physician Assistant national average
- MIPS Final Score
- 90.1/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Physician Assistant) - 90.1/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Bindu Alakot, P.A.-C appears in the CMS NPPES registry as a Physician Assistant provider holding P.A.-C credentials at 8668 SKILLMAN ST, Dallas, TX, 75243, with a listed phone of (214) 349-4909. NPI 1821312026 was issued on 03/17/2010.
Medicare Part D records for calendar year 2023 show 1,108 prescription claims written by this provider, covering 411 Medicare beneficiaries and totaling roughly $70K in drug spend, split 13% brand-name and 85% generic by claim count, with an opioid prescribing rate of 3.2%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 90.1/100 for the 2023 performance year (Quality 85.1, Cost 63.5), compared with the national average of 83.1.
Physician Assistant is a high-volume specialty nationwide, with 149,975 enrolled providers across 56 states and an average of 790 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1821312026 |
|---|---|
| Specialty | Physician Assistant |
| Credentials | P.A.-C |
| Gender | Female |
| NPI Issued | 03/17/2010 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
90.1335
Final Score
Avg: 83.1
85.1149
Quality
63.4986
Cost
88
Promoting Interoperability
Reporting: Group practice
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Bindu Alakot, P.A.-C. To verify Bindu Alakot, P.A.-C's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Bindu Alakot, P.A.-C - brand share 13.0%
Physician Assistant average
13% brand-name claims vs 85% generic, on 1,108 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,108
Total Claims
$70K
Total Drug Cost
411
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,714
- Total Day Supply
- 46,935
- Brand vs Generic
- 13% brand / 85% generic
- Brand Drug Cost
- $55K
- Generic Drug Cost
- $14K
- Opioid Claims
- 35 (3.2% rate)
- Antibiotic Claims
- 70
Patient Demographics
- Average Patient Age
- 68.0 years
- Avg HCC Risk Score
- 1.56
- Gender Split
- 62% female / 38% male
- Age Distribution
- <65: 116, 65-74: 204, 75-84: 75, 85+: 16
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Bindu Alakot, P.A.-C prescribes most
Top Medicare Part D drugs by claim count, 2023
- Amlodipine Besylate
Amlodipine Besylate
98 claims
- Atorvastatin Calcium
Atorvastatin Calcium
71 claims
- Fluticasone Propio…
Fluticasone Propionate
52 claims
- Lisinopril 38
Lisinopril
38 claims
- Gabapentin 33
Gabapentin
33 claims
- Ibuprofen 33
Ibuprofen
33 claims
- Metformin Hcl 32
Metformin Hcl
32 claims
- Cyclobenzaprine Hcl 30
Cyclobenzaprine Hcl
30 claims
| Drug | Claims |
|---|---|
| Amlodipine Besylate | 98 |
| Atorvastatin Calcium | 71 |
| Fluticasone Propionate | 52 |
| Lisinopril | 38 |
| Gabapentin | 33 |
| Ibuprofen | 33 |
| Metformin Hcl | 32 |
| Cyclobenzaprine Hcl | 30 |
| Hydrochlorothiazide | 29 |
| Tramadol Hcl | 27 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Physician Assistant Overview
How Bindu Alakot, P.A.-C fits within the Physician Assistant landscape nationally.
149,975
Physician Assistant Providers in US
56
States with Physician Assistant
790
Avg Claims per Provider
Bindu Alakot, P.A.-C's 1,108 claims are above the specialty average of 790.
Nearby Physician Assistant Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Alakot.
Dr. Neha Aamir
PA
Pearland, TX
Dr. Shaghayegh Ababaf
PA-C
Lewisville, TX
Dr. Linda Abad
PA-C
Houston, TX
Hansaa Abbasi
Dallas, TX
Dr. Alicia Abbey
MPAS, PA-C
San Antonio, TX
Compare Physician Assistant nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Texas medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Physician Assistant peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Texas
Frequently Asked Questions
What is Bindu Alakot, P.A.-C's specialty? ▼
Bindu Alakot, P.A.-C specializes in Physician Assistant and practices in Dallas, Texas. Credentials: P.A.-C.
How much does Bindu Alakot, P.A.-C prescribe under Medicare Part D? ▼
In 2023, Bindu Alakot, P.A.-C wrote 1,108 Medicare Part D claims totaling $70K in drug costs for 411 beneficiaries.
What is Bindu Alakot, P.A.-C's Medicare quality score? ▼
Bindu Alakot, P.A.-C has a CMS MIPS Final Score of 90.1/100 (Quality: 85.1, Cost: 63.5). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Bindu Alakot, P.A.-C located? ▼
Bindu Alakot, P.A.-C is located at 8668 SKILLMAN ST, Dallas, TX, 75243. Phone: (214) 349-4909.
What is Bindu Alakot, P.A.-C's NPI number? ▼
Bindu Alakot, P.A.-C's National Provider Identifier (NPI) is 1821312026, issued on 03/17/2010.
Does Bindu Alakot, P.A.-C prescribe more brand-name or generic drugs? ▼
Bindu Alakot, P.A.-C's prescribing is 13% brand-name and 85% generic drugs by claim count, with $55K in brand drug costs.
Does Bindu Alakot, P.A.-C prescribe opioids? ▼
Yes, Bindu Alakot, P.A.-C had 35 opioid claims in 2023 with an opioid prescribing rate of 3.2%.
How many Physician Assistant providers are there in the US? ▼
There are 149,975 Physician Assistant providers across 56 states in the US. The average Physician Assistant provider writes 790 Medicare Part D claims per year.
What drugs does Bindu Alakot, P.A.-C prescribe most often? ▼
Based on 2023 Medicare Part D data, Bindu Alakot, P.A.-C's most frequently prescribed drugs include Amlodipine Besylate, Atorvastatin Calcium, Fluticasone Propionate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Bindu Alakot, P.A.-C accept Medicare? ▼
Bindu Alakot, P.A.-C appears in CMS Medicare data with 1,108 Part D claims and 411 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Bindu Alakot, P.A.-C's credentials? ▼
Bindu Alakot, P.A.-C's NPI is 1821312026 with credentials P.A.-C. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.